FREE Certified Clinical Research Associate Questions and Answers

Question 1

What is the name of the document that the site must sign and date before making a QV appointment?

Accepted Answer

A CDA

Answer

Before a Qualification Visit (QV) or any initial site contact involving confidential study information, a Confidential Disclosure Agreement (CDA), also known as a Non-Disclosure Agreement (NDA), must be signed. This legal document ensures that proprietary information shared by the sponsor or CRO with the site during the evaluation process remains confidential.

Question 2

Define pharmacokinetics.

Accepted Answer

The study of drug movement throughout the body

Answer

Pharmacokinetics is a branch of pharmacology that describes how the body affects a drug. It specifically focuses on the processes of absorption, distribution, metabolism, and excretion (ADME) of a drug within the body. Understanding pharmacokinetics is crucial for determining appropriate drug dosages and regimens.

Question 3

What phase is the patient NOT healthy?

Accepted Answer

At phase 2

Answer

In clinical trials, Phase 1 studies typically involve a small group of healthy volunteers to assess drug safety and dosage. Phase 2 studies, however, involve a larger group of patients who actually have the condition the drug is intended to treat. Therefore, patients in Phase 2 are generally not healthy, as the drug's efficacy and further safety are being evaluated in the target population.

Question 4

Standard of care (SOC) is defined as.

Accepted Answer

The normal care provided per the sites guidelines

Answer

Standard of Care (SOC) refers to the typical, accepted medical treatment or practice for a particular disease or condition, as determined by professional consensus and guidelines. In clinical trials, the SOC often serves as a comparator arm against which the investigational drug's efficacy and safety are measured, representing the best available treatment outside of the study.

Question 5

Who is present when a SIV occurs?

Accepted Answer

During a SIV the PI, Sub I, SC, and other key staff are present.

Answer

A Site Initiation Visit (SIV) is a crucial meeting held before a clinical trial begins patient enrollment. During an SIV, the Principal Investigator (PI), Sub-Investigators (Sub I), Study Coordinator (SC), and other key site staff involved in the trial are present. This ensures that all personnel understand the protocol, their roles, regulatory requirements, and study procedures.

CCRA - Certified Clinical Research Associate Practice Test

CCRA - Certified Clinical Research Associate Practice Test

FREE Certified Clinical Research Associate Questions and Answers